Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 127 clinical trials
64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum)

This phase II trial is assessing how 64Cu-ATSM (64Cu-copper(II) diacetylbis(N4-methylthiosemicarbazone)) PET/CT scan could predict neo adjuvant treatment response in rectum cancer locally

metastasis
adenocarcinoma
  • 0 views
  • 24 Jan, 2021
  • 4 locations
18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients

arabinoside with PET-CT may help doctors plan better treatment for patients with solid tumors. 18F-fluoroazomycin arabinoside may help to show how much oxygen is present in a tumor during a PET-CT scan.

ct scan
solid tumour
mammogram
  • 6 views
  • 14 Mar, 2021
  • 2 locations
Gallium Ga 68-DOTATATE PET/CT in Predicting Tumor Growth in Patients With Meningiomas

Gallium Ga 68-DOTATATE before PET/CT scan may work better in predicting tumor growth in patients with meningiomas.

ct scan
residual tumor
dotatate
positron emission tomography
  • 26 views
  • 24 Jan, 2021
  • 1 location
A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma

PET/CT scan for clinical staging and a VATS procedure to acquire pretreatment tissue. Three cycles of pembrolizumab will then be administered (200 mg IV every 21 days). A PET/CT scan will then

resectable malignant pleural mesothelioma
pemetrexed
pleurectomy
thoracoscopy
neutrophil count
  • 29 views
  • 24 Jan, 2021
  • 1 location
CPET in Myocardial Ischemia

recruit patients who have been referred to myocardial perfusion PET/CT scan in Kuopio University Hospital. The participants will perform the CPET on a cycle ergometer on separate day after the perfusion

  • 0 views
  • 23 Jan, 2021
  • 1 location
Neo-adjuvant Trial With AZD9291 in EGFRm+ Stage IIIA/B NSCLC

Patients will receive AZD9291 at a dose of 80 mg once daily. Systemic evaluation will be done by PET-CT scan after 6 weeks. In responding patients AZD9291 will be given orally 80 mg daily

cancer chemotherapy
egfr t790m
neutrophil count
ct scan
measurable disease
  • 0 views
  • 24 Jan, 2021
  • 1 location
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules

imaging agent called 18F-FDG is often used in combination with a PET/CT scanner to evaluate cancers. Giving 18F-FSPG before a PET/CT scan may work better in helping researchers diagnose early lung cancer

lung cancer
cancer
early diagnosis
ct scan
pet/ct scan
  • 0 views
  • 24 Mar, 2021
  • 1 location
Evaluation of Neuroinflammation in Parkinson's Disease Using 18F-NOS PET/CT

The research study is being conducted to test how a specialized type of Positron Emission Tomography (PET/CT) scan could potentially be useful in diagnosing or monitoring treatment in people

ct scan
positron emission tomography
  • 4 views
  • 25 Jan, 2021
  • 1 location
68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer

) works in detecting regional nodal and distant metastases in patients with intermediate or high-risk prostate cancer. 68Ga-RM2 PET/CT scan may be able to see smaller tumors than the standard of care CT

  • 7 views
  • 27 Jan, 2021
  • 1 location
Study of TLR9 Agonist CMP-001 in Combination With Nivolumab vs. Nivolumab

areas. The main goal of the PET/CT scan with 18F]F-AraG is to evaluate how [18F]F-AraG uptake changes before and after administration of either nivolumab or nivolumab/CMP-001 combination.

serum pregnancy test
braf inhibitor
direct bilirubin
lung cancer
metastasis
  • 0 views
  • 26 Jan, 2021
  • 1 location